Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 2/20 | 0.55 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 5/20 | 0.48 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7663741 | 0.87 | HRH1 (0.69) | OPRM1HRH1HRH3ADRA1AADRA1D | |
| SCHEMBL7651533 | 0.83 | HRH1 (0.61) | OPRM1HRH1HRH3ADRA1AADRA1D | |
| SCHEMBL7654432 | 0.81 | HRH1 (0.61) | OPRM1HRH1HRH3ADRA1AADRA1D | |
| Hydrochloric Acid SCHEMBL7654453 | 0.81 | HRH1 (0.60) | OPRM1HRH1HRH3ADRA1AADRA1D | |
| SCHEMBL6198215 | 0.79 | OPRM1 (0.62) | OPRM1ADRA1AADRA1DADRA1B | |
| SCHEMBL27796310 | 0.76 | OPRM1 (0.71) | OPRM1HRH3ADRA1AADRA1DADRA1B | |
| SCHEMBL7867870 | 0.76 | OPRM1 (0.45) | OPRM1 | |
| SCHEMBL25284731 | 0.75 | HTR1A (0.62) | SIGMAR1 | |
| SCHEMBL25236902 | 0.75 | HTR7 (0.64) | SIGMAR1 | |
| Hydrochloric Acid SCHEMBL10626602 | 0.75 | OPRM1 (0.69) | OPRM1HRH3ADRA1AADRA1DADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6436962-B1 | ALPHA 1A ADRENERGIC RECEPTOR ANTAGONISTS; RELIEF FROM BENIGN PROSTATIC HYPERPLASIA BY LESS HINDERED URINE FLOW BY RELAXING SMOOTH MUSCLE TISSUE; WITH A TESTOSTERONE 5-ALPHA REDUCTASE INHIBITOR, FINASTERIDE; ACUTE AND CHRONIC RELIEF | MERCK & CO., INC. | 2002-08-20 | — | — | US | disclosed |